Search
for
Sort by
Research 31–60 of 365
- Formulation and Evaluation of Herbal Shampoo
- An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil
- Active Compounds with Medicinal Potential Found in Maxillariinae Benth. (Orchidaceae Juss.) Representatives—A Review
- Diabetogenic potential of dexamethasone and effect Annona muricata methanolic bark extract as post-exposure therapy in albino rats
- Sinergitas Efek Kombinasi Ekstrak Daun SirsaK (Annona muricata Linn) Dengan Doksorubisin Pada Sel Kanker Payudara MCF-7
- Supplementary 2
- Chemotherapy-induced toxicity—a secondary effect caused by released DNA?
- Alopecia/hair loss in all patients treated with trastuzumab and paclitaxel: myth or reality?
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Trichomegaly of the eyelashes following treatment with cetuximab
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Male pattern baldness and the risk of prostate cancer
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Aromatase inhibitors induce ‘male pattern hair loss’ in women?
- Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither?
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Absence of chemotherapy-induced alopecia with paclitaxel in a case of hypothyroidism: case report
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Genetic and hormonal influence on SARS-CoV-2-infection susceptibility